---
layout: post
title:  Merck funding
date:   2023-02-01 12:00:00
categories: news
---
The lab has established an agreement with Merck to profile antibody effector responses across several dimensions. This work should provide a high resolution view of the different design variables that contribute to cell-directed immunity. The approach is modeled by work from the lab to [study other receptor families](https://www.biorxiv.org/content/10.1101/2021.07.03.451002v2).